Cargando…

miRNA–mRNA Associated With Survival in Endometrial Cancer

Although various factors may contribute to its initiation and progression, the etiology and prognostic factors of endometrial carcinoma (EC) remains not fully understood. We sought to understand the role of changes in transcriptome during the progress of EC by exploring public datasets. The aberrant...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaofeng, Liu, Tao, Wang, Yijin, Fu, Jian, Yang, Qian, Wu, Jun, Zhou, Huaijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710979/
https://www.ncbi.nlm.nih.gov/pubmed/31481972
http://dx.doi.org/10.3389/fgene.2019.00743
_version_ 1783446449748443136
author Xu, Xiaofeng
Liu, Tao
Wang, Yijin
Fu, Jian
Yang, Qian
Wu, Jun
Zhou, Huaijun
author_facet Xu, Xiaofeng
Liu, Tao
Wang, Yijin
Fu, Jian
Yang, Qian
Wu, Jun
Zhou, Huaijun
author_sort Xu, Xiaofeng
collection PubMed
description Although various factors may contribute to its initiation and progression, the etiology and prognostic factors of endometrial carcinoma (EC) remains not fully understood. We sought to understand the role of changes in transcriptome during the progress of EC by exploring public datasets. The aberrant expression characteristics of EC based on RNA-Seq and miRNA-seq data from The Cancer Genome Atlas (TCGA) were analyzed. Kaplan–Meier analysis was performed to assess the relationship between differently expressed genes (DEGs) and patient survival. As a result, 320 out of 4,613 differently expressed mRNAs (DE mRNAs) and 68 out of 531 differently expressed miRNAs (DE miRNAs) with a significantly poorer survival were determined. We predicted eight paired DE miRNAs and DE mRNAs through TargetScan. Patients with three out of the eight paired low rate of miRNA/mRNA (miR-497/EMX1, miR-23c/DMBX1, and miR-670/KCNS1) expression had a significantly poorer survival. Furthermore, the simultaneous presence of these selected low miRNA/mRNA pairs occurred in most patients and resulted in a significantly poorer survival rate. Luciferase reporter assay identified that EMX1 was a direct target of miR-497. Both low expression of miR-497 and overexpression of EMX1 were significantly associated with more advanced clinicopathologic characteristics (stage, tumor status, grade, and histology) besides survival (all P values < 0.05). Multivariate analysis also demonstrated that miR-497 remained an independent prognostic variable for overall survival. In summary, we identified that a series of DE mRNAs and miRNAs, including eight paired DE miRNAs and mRNAs, were associated with survival in EC. Clinical evaluation of downregulated miR-497 and paired upregulated EMX1 confirmed the value of our prediction analysis. The simultaneous presence of low rate of these selected low miRNA/mRNA pairs (miR-497/EMX1, miR-23c/DMBX1, and miR-670/KCNS1) might have a better prediction value. Therefore, further studies are required to validate these findings.
format Online
Article
Text
id pubmed-6710979
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67109792019-09-03 miRNA–mRNA Associated With Survival in Endometrial Cancer Xu, Xiaofeng Liu, Tao Wang, Yijin Fu, Jian Yang, Qian Wu, Jun Zhou, Huaijun Front Genet Genetics Although various factors may contribute to its initiation and progression, the etiology and prognostic factors of endometrial carcinoma (EC) remains not fully understood. We sought to understand the role of changes in transcriptome during the progress of EC by exploring public datasets. The aberrant expression characteristics of EC based on RNA-Seq and miRNA-seq data from The Cancer Genome Atlas (TCGA) were analyzed. Kaplan–Meier analysis was performed to assess the relationship between differently expressed genes (DEGs) and patient survival. As a result, 320 out of 4,613 differently expressed mRNAs (DE mRNAs) and 68 out of 531 differently expressed miRNAs (DE miRNAs) with a significantly poorer survival were determined. We predicted eight paired DE miRNAs and DE mRNAs through TargetScan. Patients with three out of the eight paired low rate of miRNA/mRNA (miR-497/EMX1, miR-23c/DMBX1, and miR-670/KCNS1) expression had a significantly poorer survival. Furthermore, the simultaneous presence of these selected low miRNA/mRNA pairs occurred in most patients and resulted in a significantly poorer survival rate. Luciferase reporter assay identified that EMX1 was a direct target of miR-497. Both low expression of miR-497 and overexpression of EMX1 were significantly associated with more advanced clinicopathologic characteristics (stage, tumor status, grade, and histology) besides survival (all P values < 0.05). Multivariate analysis also demonstrated that miR-497 remained an independent prognostic variable for overall survival. In summary, we identified that a series of DE mRNAs and miRNAs, including eight paired DE miRNAs and mRNAs, were associated with survival in EC. Clinical evaluation of downregulated miR-497 and paired upregulated EMX1 confirmed the value of our prediction analysis. The simultaneous presence of low rate of these selected low miRNA/mRNA pairs (miR-497/EMX1, miR-23c/DMBX1, and miR-670/KCNS1) might have a better prediction value. Therefore, further studies are required to validate these findings. Frontiers Media S.A. 2019-08-20 /pmc/articles/PMC6710979/ /pubmed/31481972 http://dx.doi.org/10.3389/fgene.2019.00743 Text en Copyright © 2019 Xu, Liu, Wang, Fu, Yang, Wu and Zhou http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Xu, Xiaofeng
Liu, Tao
Wang, Yijin
Fu, Jian
Yang, Qian
Wu, Jun
Zhou, Huaijun
miRNA–mRNA Associated With Survival in Endometrial Cancer
title miRNA–mRNA Associated With Survival in Endometrial Cancer
title_full miRNA–mRNA Associated With Survival in Endometrial Cancer
title_fullStr miRNA–mRNA Associated With Survival in Endometrial Cancer
title_full_unstemmed miRNA–mRNA Associated With Survival in Endometrial Cancer
title_short miRNA–mRNA Associated With Survival in Endometrial Cancer
title_sort mirna–mrna associated with survival in endometrial cancer
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710979/
https://www.ncbi.nlm.nih.gov/pubmed/31481972
http://dx.doi.org/10.3389/fgene.2019.00743
work_keys_str_mv AT xuxiaofeng mirnamrnaassociatedwithsurvivalinendometrialcancer
AT liutao mirnamrnaassociatedwithsurvivalinendometrialcancer
AT wangyijin mirnamrnaassociatedwithsurvivalinendometrialcancer
AT fujian mirnamrnaassociatedwithsurvivalinendometrialcancer
AT yangqian mirnamrnaassociatedwithsurvivalinendometrialcancer
AT wujun mirnamrnaassociatedwithsurvivalinendometrialcancer
AT zhouhuaijun mirnamrnaassociatedwithsurvivalinendometrialcancer